InMed’s Senior VP, Preclinical Research and Development, Dr. Eric Hsu, join the Benzinga Small Cap Conference Panel Discussion “Pharmaceutical Cannabinoids and their Impact on Treatments for Complex Diseases”.
Panel members included:
Pnina Fishman – CEO at Can-Fite Biopharma
Karam Takhar – VP, Corporate Development & Investor Relations Skye Bioscience Inc.
David Elsley – CEO at Cardiol Therapeutics Inc.
Eric C. Hsu, PhD – SVP, Pre-Clinical Research & Development InMed Pharma
Moderator: Javier Hasse Director, Cannabis, Benzinga
The Benzinga Global Small Cap Conference bridges the gap between Small Cap companies, investors, and traders. Learn about small cap investing with clearly defined Educational Modules, take a look at a curated group of Small Cap investment opportunities, and connect with the global Small Cap audience in an intimate, virtual setting.
To learn more visit the Benzinga Small Cap conference website.
